Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 24,851–24,900 of 25,420 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04186013	Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer	active not recruiting	Phase 2	39	Spanish Oncology Genito-Urinary GroupOTHER	1	Oct 26, 2022	clinicaltrials
NCT05244798	Sintilimab Plus NCT or NCRT Versus NCRT for ESCC	not yet recruiting	Phase 3	420	Sichuan Cancer Hospital and Research InstituteOTHER	1	Oct 25, 2022	clinicaltrials